What is she best known for?
The fields of study she is best known for:
Elisabeth Stockert spends much of her time researching Antigen, Antibody, Immunology, NY-ESO-1 and Cancer/testis antigens.
Her Antigen research incorporates elements of Immunohistochemistry, Pathology, Cancer, Melanoma and Cytotoxic T cell.
Elisabeth Stockert has researched Melanoma in several fields, including Bladder cancer and Prostate cancer.
Her research on Antibody often connects related topics like Molecular biology.
Her work is dedicated to discovering how Molecular biology, cDNA library are connected with Genomic library and other disciplines.
Her Immunogenicity research is multidisciplinary, incorporating perspectives in Complementary DNA and Adenocarcinoma.
Her most cited work include:
- A cell cycle regulator potentially involved in genesis of many tumor types (2568 citations)
- Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice (1196 citations)
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening (1112 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Antigen, Molecular biology, Antibody, Monoclonal antibody and Immunology.
Her studies in Antigen integrate themes in fields like Cancer, Virology, Immune system, Cytotoxic T cell and Leukemia.
She focuses mostly in the field of Cancer, narrowing it down to matters related to Cancer research and, in some cases, Epidermal growth factor receptor.
Her studies deal with areas such as Cell, Gene, Recombinant DNA, Genetics and C57BL/6 as well as Molecular biology.
The Antibody study combines topics in areas such as In vitro, In vivo and NY-ESO-1.
Her study on Monoclonal antibody also encompasses disciplines like
- Immunohistochemistry which is related to area like Melanocyte differentiation and Melanoma,
- Adjuvant that connect with fields like Tumor rejection antigen.
She most often published in these fields:
- Antigen (57.25%)
- Molecular biology (45.65%)
- Antibody (35.51%)
What were the highlights of her more recent work (between 2001-2021)?
- Antibody (35.51%)
- Antigen (57.25%)
- Cancer (18.84%)
In recent papers she was focusing on the following fields of study:
Elisabeth Stockert mostly deals with Antibody, Antigen, Cancer, Molecular biology and Immunology.
Her biological study spans a wide range of topics, including NY-ESO-1 and Immunotherapy.
Her work deals with themes such as Immunohistochemistry, Pathology and Tumor antigen, which intersect with NY-ESO-1.
The various areas that Elisabeth Stockert examines in her Antigen study include Gene expression, T cell, Immune system, Serology and Monoclonal antibody.
Her Molecular biology study integrates concerns from other disciplines, such as cDNA library, Antigen-presenting cell, Gene product and Virology.
Her work in Immunology addresses subjects such as Synovial sarcoma, which are connected to disciplines such as Immunogenicity, Melanoma-Specific Antigens, Pan-T antigens and Humoral immunity.
Between 2001 and 2021, her most popular works were:
- NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. (194 citations)
- Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. (190 citations)
- Identification of cancer/testis genes by database mining and mRNA expression analysis. (123 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in Antibody, Antigen, Pathology, Immunohistochemistry and Cancer.
Elisabeth Stockert works in the field of Antibody, namely Monoclonal antibody.
Her Pathology research integrates issues from Epitope, Ovary, Ovarian cancer and NY-ESO-1.
Immunohistochemistry is closely attributed to Cancer/testis antigens in her research.
Her research in Cancer intersects with topics in Immunology, cDNA library, Molecular biology, Regulation of gene expression and Gene product.
Her study in Immunology is interdisciplinary in nature, drawing from both Sarcoma and Synovial sarcoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
